BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10600286)

  • 1. Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervix.
    Hanselaar AG; Boss EA; Massuger LF; Bernheim JL
    Gynecol Oncol; 1999 Dec; 75(3):338-44. PubMed ID: 10600286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
    Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
    Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
    Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
    Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
    van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
    Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero diethylstilbestrol exposure: structural and epithelial abnormalities.
    Noller KL
    Cervix Low Female Genital Tract; 1983; 1(2):75-82. PubMed ID: 12266371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical and vaginal cytologic smears suggestive of adenocarcinoma.
    Pretorius R; Binstock M; Sadeghi M; Hodges W
    J Reprod Med; 1996 Jul; 41(7):478-82. PubMed ID: 8829059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
    Hall WB; Detterbeck FC; Livasy CA; Fowler WC
    Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
    Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
    Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol.
    Camp EA; Coker AL; Troisi R; Robboy SJ; Noller KL; Goodman KJ; Titus-Ernstoff LT; Hatch EE; Herbst AL; Kaufman RH; Adam E
    J Low Genit Tract Dis; 2008 Apr; 12(2):111-7. PubMed ID: 18369304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
    Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
    J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.
    Hanselaar A; van Loosbroek M; Schuurbiers O; Helmerhorst T; Bulten J; Bernhelm J
    Cancer; 1997 Jun; 79(11):2229-36. PubMed ID: 9179071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cytologic and histopathologic diagnosis to detect carcinoma of the vagina and uterus in postmenopausal women. Effect of vaginal stenosis on diagnosis and treatment.
    Jones EG
    Trans Pac Coast Obstet Gynecol Soc; 1970; 38():44-51. PubMed ID: 5522651
    [No Abstract]   [Full Text] [Related]  

  • 16. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cytology. Increased sensitivity with a second cervical smear.
    Luthy DA; Briggs RM; Buyco A; Eschenbach A
    Obstet Gynecol; 1978 Jun; 51(6):713-7. PubMed ID: 662251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of an adolescent with locally advanced cervicovaginal clear cell adenocarcinoma using definitive chemotherapy and radiotherapy.
    Ansari DO; Horowitz IR; Katzenstein HM; Durham MM; Esiashvili N
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):e174-6. PubMed ID: 22713709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
    Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.